RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 79 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $98,000 | -55.7% | 17,933 | -21.0% | 0.00% | – |
| Q4 2021 | $221,000 | -50.7% | 22,695 | -9.5% | 0.00% | -100.0% |
| Q3 2021 | $448,000 | -33.8% | 25,066 | -9.7% | 0.00% | -50.0% |
| Q2 2021 | $677,000 | +22.9% | 27,744 | +33.4% | 0.00% | 0.0% |
| Q1 2021 | $551,000 | +255.5% | 20,802 | +1.8% | 0.00% | +100.0% |
| Q4 2020 | $155,000 | +78.2% | 20,425 | +17.3% | 0.00% | – |
| Q3 2020 | $87,000 | -17.9% | 17,410 | -1.8% | 0.00% | -100.0% |
| Q2 2020 | $106,000 | +82.8% | 17,731 | +36.0% | 0.00% | – |
| Q1 2020 | $58,000 | -72.2% | 13,038 | -40.7% | 0.00% | -100.0% |
| Q4 2019 | $209,000 | +4.5% | 21,994 | -13.9% | 0.00% | 0.0% |
| Q3 2019 | $200,000 | -52.8% | 25,540 | -5.2% | 0.00% | -66.7% |
| Q2 2019 | $424,000 | -23.3% | 26,942 | -11.8% | 0.00% | 0.0% |
| Q1 2019 | $553,000 | +22.6% | 30,559 | +8.8% | 0.00% | 0.0% |
| Q4 2018 | $451,000 | – | 28,076 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abbot Financial Management, Inc. | 1,411,775 | $25,243,000 | 11.48% |
| Flagship Pioneering Inc. | 38,506,526 | $688,497,000 | 7.21% |
| Artal Group S.A. | 4,155,625 | $74,303,000 | 1.66% |
| HARBOURVEST PARTNERS LLC | 986,878 | $17,645,000 | 1.66% |
| Nan Fung Group Holdings Ltd | 56,768 | $1,015,000 | 0.32% |
| Lombard Odier Asset Management (Switzerland) SA | 245,013 | $4,381,000 | 0.27% |
| Bellwether Advisors, LLC | 29,383 | $525,000 | 0.18% |
| PDT Partners, LLC | 65,991 | $1,180,000 | 0.08% |
| Virtus ETF Advisers LLC | 7,478 | $134,000 | 0.06% |
| HITE Hedge Asset Management LLC | 24,911 | $445,000 | 0.06% |